Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.52 | 13.17 |
| PEG Ratio (TTM) | -0.24 | 2.21 |
| P/S Ratio (TTM) | 1.01 | 2.55 |
| P/B Ratio (TTM) | 1.13 | 1.79 |
| P/FCF Ratio (TTM) | 25.49 | 25.91 |
| Price to 5YR AVG Earnings Ratio | 4.55 | 16.60 |
| Price to 5YR AVG FCF Ratio | 19.47 | 32.40 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.75% | 5.72% |
| ROE (TTM) | 8.24% | 13.98% |
| Net Profit Margin (TTM) | 7.57% | 19.23% |
| ROIC 5YR AVG | 5.92% | 3.15% |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 327.60% | 18,884.44% | 11,322.25% |
| Revenue | -4.69% | 3.76% | 0.76% |
| Net Income | 288.26% | 18,634.50% | 11,167.56% |
| Cash Flow | 107.27% | -301.52% | -177.83% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 5.78 |
| Quick Ratio (TTM) | 1.67 | 5.05 |
| D/E Ratio (TTM) | 0.49 | 0.26 |
| Interest Coverage (TTM) | 3.10 | 9.49 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 1.14 | 2.56 |
| LTL to 5YR AVG FCF | 9.62 | 4.18 |
| Shares Outstanding Growth 5YR AVG | -4.29% | -2.34% |